Pattern and Outcome of Acute Non-ST-Segment Elevation Myocardial Infarction Seen in Adult Emergency Department of Al-Shaab Teaching Hospital: A prospective Observational Study in a Tertiary Cardiology Center.
acute myocardial injury
cardio protection
cardiovascular medicine. hypertensive heart disease. cardio-oncology. cardiac mri
non-st elevated myocardial infarction
primary pci
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
accepted:
14
09
2021
entrez:
20
9
2021
pubmed:
21
9
2021
medline:
21
9
2021
Statut:
epublish
Résumé
Background Despite investments to improve the quality of emergency care for patients with acute myocardial infarction (AMI), few studies have described national, real-world trends in non-ST elevation myocardial infarction (NSTEMI) care in the emergency department (ED). We aimed to describe the characteristics, management, and outcomes of NSTEMI. Methods A prospective single-center study enrolled 40 NSTEMI patients in Alshaab Teaching Hospital during the period from May to July 2021. Data regarding demographics, medical history, clinical presentations, laboratory investigation, Killip classifications, electrocardiography (ECG), echocardiogram, diagnostic coronary angiography (CAG), management strategies, medications used, and 30-days outcomes were collected. Results Among 40 patients, NSTEMI was common in the age groups from 56 to 70 years (60%) and males (67.5%; p=0.002). Diabetes (n=24; 60%) and hypertension (n=20; 50%) were the major cardiovascular disease (CVD) risk factors. In most of the cases, 29 (72%) had a late presentation (>6 hours; p=0.0001). In Killip classifications, 36 (90%) patients were Killip class I and four (10%) were Killip class II (p=0.005). No patients underwent risk score assessment during a hospital stay. All patients had sinus rhythm in ECG and 28 (70%) had T-wave inversion. An echocardiogram was performed for 36 (90%) patients, among them six (16.7%) patients had LV systolic dysfunction (p=.003). The median ejection fraction was 52% (ranged from 25-75%). Diagnostic CAG was performed for 38 (95%) patients and a stent was inserted for 23 (58%) of them. The major final management strategy among our study group was PCI in 23 (58%) patients. All patients received aspirin, clopidogrel, parenteral anticoagulant, and ACEi/ARBs, 38 (95%) had statin, 28 (70%) were given PPI, and seven (17.5%) received diuretics. As for 30-day outcomes, all patients survived, but ten (25%) patients were readmitted, and no in-hospital or 30-days mortality occurred. Conclusion NSTEMI predominantly affected male and older patients. Most of them had a delayed presentation to ED. Hypertension and DM were the major risk factors. All patients were in sinus rhythm and the main ECG abnormality was a T-wave inversion. Most of the patients received standard NSTEMI protocol with exception of risk stratification. PCI was the major final management strategy used. Albeit no in-hospital or 30-days mortality occurred, 25% were readmitted.
Identifiants
pubmed: 34540510
doi: 10.7759/cureus.17981
pmc: PMC8441114
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e17981Informations de copyright
Copyright © 2021, Abdelhameed et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Am J Med. 2011 Jan;124(1):40-7
pubmed: 21187184
JAMA. 2016 Sep 13;316(10):1073-82
pubmed: 27574717
JAMA. 2007 Jan 10;297(2):177-86
pubmed: 17213401
BMC Cardiovasc Disord. 2007 Mar 05;7:8
pubmed: 17338808
N Engl J Med. 2010 Jun 10;362(23):2155-65
pubmed: 20558366
Lancet. 2008 Aug 16;372(9638):570-84
pubmed: 18707987
J Cardiothorac Vasc Anesth. 2019 Aug;33(8):2334-2343
pubmed: 30482703
N Engl J Med. 2012 Aug 2;367(5):391-3
pubmed: 22784039
BMJ. 2006 Nov 25;333(7578):1091
pubmed: 17032691
Circ Cardiovasc Qual Outcomes. 2017 Jun;10(6):
pubmed: 28630371
Eur Heart J Acute Cardiovasc Care. 2015 Dec;4(6):537-54
pubmed: 25214638
BMC Emerg Med. 2018 Dec 3;18(1):50
pubmed: 30509187
BMJ. 2012 Jan 25;344:d8059
pubmed: 22279113
Int J Cardiol. 2011 Oct 6;152(1):70-7
pubmed: 20684999
Clin Cardiol. 2015 Feb;38(2):121-3
pubmed: 25648849
Am Heart J. 2008 Dec;156(6):1045-55
pubmed: 19032998
Med Care. 2013 Aug;51(8):689-98
pubmed: 23752257
Eur Heart J. 2016 Jan 14;37(3):267-315
pubmed: 26320110
Am J Cardiol. 2007 Jul 15;100(2):190-5
pubmed: 17631068
Eur Heart J. 2017 Apr 1;38(13):974-982
pubmed: 28329279
J Am Coll Cardiol. 2012 Oct 16;60(16):1581-98
pubmed: 22958960
J Family Community Med. 2016 May-Aug;23(2):100-4
pubmed: 27186156
Rev Esp Cardiol. 2011 Nov;64(11):1060-4
pubmed: 21700375
Eur Heart J Qual Care Clin Outcomes. 2016 Jul 1;2(3):172-183
pubmed: 29474617
Can J Cardiol. 2006 Jun;22(8):663-77
pubmed: 16801997
BMJ. 2009 Jan 26;338:b36
pubmed: 19171564
Am Heart J. 2008 Dec;156(6):1026-34
pubmed: 19032996